Discontinued — last reported Q3 '19
Current Liabilities
Accrued Expenses
STERIS Accrued Expenses increased by 10.3% to $81.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.6%, from $69.78M to $81.40M. Over 4 years (FY 2021 to FY 2025), Accrued Expenses shows an upward trend with a 9.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2019
How to read this metric
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
Detailed definition
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Peer comparison
Standard current liability found in almost all corporate balance sheets.
Metric ID:
accrued_expensesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $81.75M | $90.35M | $95.88M | $78.39M | $91.39M | $72.65M | $64.34M | $87.61M | $87.83M | $57.65M | $62.22M | $83.11M | $39.49M | $58.19M | $69.78M | $82.80M | $79.10M | $73.80M | $81.40M |
| QoQ Change | — | +10.5% | +6.1% | -18.2% | +16.6% | -20.5% | -11.4% | +36.2% | +0.2% | -34.4% | +7.9% | +33.6% | -52.5% | +47.4% | +19.9% | +18.7% | -4.5% | -6.7% | +10.3% |
| YoY Change | — | — | — | — | +11.8% | -19.6% | -32.9% | +11.8% | -3.9% | -20.6% | -3.3% | -5.1% | -55.0% | +0.9% | +12.2% | -0.4% | +100.3% | +26.8% | +16.6% |
Range$39.49M – $95.88M
CAGR-0.1%
Avg YoY Growth+2.6%
Median YoY Growth-0.4%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is STERIS's accrued expenses?
- STERIS (STE) reported accrued expenses of $81.40M in Q4 2025.
- How has STERIS's accrued expenses changed year-over-year?
- STERIS's accrued expenses increased by 16.6% year-over-year, from $69.78M to $81.40M.
- What is the long-term trend for STERIS's accrued expenses?
- Over 4 years (2021 to 2025), STERIS's accrued expenses has grown at a 9.5% compound annual growth rate (CAGR), from $57.55M to $82.80M.
- What does accrued expenses mean?
- Expenses the company has incurred but has not yet received a bill for or paid.